Biopharmaceutical
- All
- News
- Videos
-
How Iran Immigrant Maky Zanganeh Is Now A Self-Made Billionaire In US
Maky Zanganeh became a billionaire after shares of Summit Therapeutics, where she serves as co-CEO, soared following positive trial data for its promising cancer drug.
-
"I Donated To...": Biocon Head Kiran Mazumdar-Shaw On "Nominal" Electoral Bonds
Biocon Ltd Executive Chairperson Kiran Mazumdar-Shaw on Monday said that her Bengaluru-based biopharmaceuticals firm did not make any donations to any political party using electoral bonds.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
"Devastated": Biocon Chief Kiran Mazumdar Shaw Mourns Vikram Kirloskar
Executive Chairperson of biopharmaceuticals Biocon Kiran Mazumdar-Shaw has expressed grief over the sudden demise of Vikram S. Kirloskar.
-
Samsung to Invest $356 Billion by 2026 to Accelerate Growth in Chip Sector, Biopharma, Next-Gen Technology
Samsung Electronics announced on Tuesday to invest $356 billion over the next five years in strategic sectors. The South Korean company is looking forward to accelerate long-term growth in semiconductors, biopharmaceutical and other next-generation technologies.
-
An Indian Pharma Is Working On Omicron-Specific Vaccine: Report
India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.
-
India's 1st Homegrown mRNA Vaccine Approved For More Clinical Trials
Pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday.
-
Samsung to Invest KRW 240 Trillion Over Next Three Years; Expand Into AI, Robotics, More Industries
Samsung Group will invest KRW 240 trillion (roughly Rs. 15,26,645 crores) in the next three years to expand footprint in biopharmaceutical, artificial intelligence, semiconductor, and robotics industries in the post-pandemic era, Samsung Electronics said.
-
25,000 Doses Of Remdesivir From Gilead Sciences Reach India
The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday.
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
AstraZeneca Moves From Favored Child To Problem Child Among Vaccines
Mene Pangalos, head of biopharmaceuticals research for AstraZeneca Plc, went to bed on Monday, March 22, feeling good for the first time in a while.
-
India's First Homemade mRNA Vaccine Gets Permission To Start Human Trials
An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
Envoys From 100 Countries To Visit Pune On December 4 Amid Vaccine Production
Ambassadors and envoys from 100 countries will visit Serum Institute of India and Gennova Biopharmaceuticals Ltd in Pune on December 4 amid the coronavirus outbreak and race for vaccines to combat the infection, a senior official said on Tuesday.
-
Top Health Body, Firm Develop "Antisera" As Potential COVID-19 Treatment
The Indian Council of Medical Research (ICMR) in collaboration with a Hyderabad-based biopharmaceutical company has developed "highly purified antisera" prepared by injecting inactivated SARS-CoV2 in horses, which can be a potential treatment for COVID-19.
-
How Iran Immigrant Maky Zanganeh Is Now A Self-Made Billionaire In US
Maky Zanganeh became a billionaire after shares of Summit Therapeutics, where she serves as co-CEO, soared following positive trial data for its promising cancer drug.
-
"I Donated To...": Biocon Head Kiran Mazumdar-Shaw On "Nominal" Electoral Bonds
Biocon Ltd Executive Chairperson Kiran Mazumdar-Shaw on Monday said that her Bengaluru-based biopharmaceuticals firm did not make any donations to any political party using electoral bonds.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
"Devastated": Biocon Chief Kiran Mazumdar Shaw Mourns Vikram Kirloskar
Executive Chairperson of biopharmaceuticals Biocon Kiran Mazumdar-Shaw has expressed grief over the sudden demise of Vikram S. Kirloskar.
-
Samsung to Invest $356 Billion by 2026 to Accelerate Growth in Chip Sector, Biopharma, Next-Gen Technology
Samsung Electronics announced on Tuesday to invest $356 billion over the next five years in strategic sectors. The South Korean company is looking forward to accelerate long-term growth in semiconductors, biopharmaceutical and other next-generation technologies.
-
An Indian Pharma Is Working On Omicron-Specific Vaccine: Report
India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.
-
India's 1st Homegrown mRNA Vaccine Approved For More Clinical Trials
Pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday.
-
Samsung to Invest KRW 240 Trillion Over Next Three Years; Expand Into AI, Robotics, More Industries
Samsung Group will invest KRW 240 trillion (roughly Rs. 15,26,645 crores) in the next three years to expand footprint in biopharmaceutical, artificial intelligence, semiconductor, and robotics industries in the post-pandemic era, Samsung Electronics said.
-
25,000 Doses Of Remdesivir From Gilead Sciences Reach India
The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday.
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
AstraZeneca Moves From Favored Child To Problem Child Among Vaccines
Mene Pangalos, head of biopharmaceuticals research for AstraZeneca Plc, went to bed on Monday, March 22, feeling good for the first time in a while.
-
India's First Homemade mRNA Vaccine Gets Permission To Start Human Trials
An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
Envoys From 100 Countries To Visit Pune On December 4 Amid Vaccine Production
Ambassadors and envoys from 100 countries will visit Serum Institute of India and Gennova Biopharmaceuticals Ltd in Pune on December 4 amid the coronavirus outbreak and race for vaccines to combat the infection, a senior official said on Tuesday.
-
Top Health Body, Firm Develop "Antisera" As Potential COVID-19 Treatment
The Indian Council of Medical Research (ICMR) in collaboration with a Hyderabad-based biopharmaceutical company has developed "highly purified antisera" prepared by injecting inactivated SARS-CoV2 in horses, which can be a potential treatment for COVID-19.
